Fog Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.fogpharma.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1
Recruiting
- Conditions
- CancerColorectal CancerSolid TumorLocally Advanced Solid TumorMetastatic CancerWNT Pathwayβ-cateninBeta-cateninAdenomatous Polyposis ColiAPC
- Interventions
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Parabilis Medicines, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT05919264
- Locations
- 🇺🇸
Stanford Cancer Institute, Stanford University, Palo Alto, California, United States
🇺🇸University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
🇺🇸Honor Health, Scottsdale, Arizona, United States
News
No news found